ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

NXEN Nexien BioPharma Inc (QB)

0.0167
0.0004 (2.45%)
May 03 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 53,556
Bid Price 0.0142
Ask Price 0.0299
News -
Day High 0.029

Low
0.011

52 Week Range

High
0.0998

Day Low 0.0167
Company Name Stock Ticker Symbol Market Type
Nexien BioPharma Inc (QB) NXEN OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
0.0004 2.45% 0.0167 16:15:35
Open Price Low Price High Price Close Price Prev Close
0.029 0.0167 0.029 0.0167 0.0163
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
4 53,556 $ 0.028481 $ 1,525 - 0.011 - 0.0998
Last Trade Time Type Quantity Stock Price Currency
14:22:03 2,954 $ 0.0167 USD

Nexien BioPharma Inc (QB) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
1.27M 64.02M 11.59M 0 -362k -0.01 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Nexien BioPharma (QB) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No NXEN Message Board. Create One! See More Posts on NXEN Message Board See More Message Board Posts

Historical NXEN Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.01680.0290.01630.016791614,590-0.0001-0.60%
1 Month0.020260.0290.01630.01837698,980-0.00356-17.57%
3 Months0.019540.030.01510.021531810,583-0.00284-14.53%
6 Months0.0290.040.0110.022576211,685-0.0123-42.41%
1 Year0.040550.09980.0110.028333210,425-0.02385-58.82%
3 Years0.120.1950.0110.077030815,613-0.1033-86.08%
5 Years0.080.4450.00850.114993926,749-0.0633-79.13%

Nexien BioPharma (QB) Description

Nexien BioPharma Inc. is a US-based pharmaceutical company engaged in the formulation, development and commercialization of cannabinoid-based pharmaceuticals, in accordance with U.S. Food and Drug Administration ('FDA') pre-clinical and clinical pathways, to address a broad range of medical conditions and disorders. Nexien BioPharma's drug development strategy consists of: A. The determination of medical conditions and disorders that could potentially benefit from cannabinoid-based formulations; B. Conducting "freedom to operate" investigations on these conditions; C. The preparation of patent applications and the prosecution of such application and/or the licensing of existing patents; D. Identifying the regulatory pathway with the FDA; and E. Proceeding with pre-clinical and clinical development activities in accordance with FDA protocols for submission to obtain approval for the particular product(s).

Your Recent History

Delayed Upgrade Clock